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Background:  Premature infants are at high risk of having persistence of ductal patency which may lead to volume overload of the 
pulmonary vascular bed and the left heart. Indomethacin has been utilized as an alternative to surgical ligation of patent arterial ducts but 
has been associated with adverse events such as bronchopulmonary dysplasia, necrotizing enterocolitis, and renal dysfunction. Ibuprofen 
has been suggested as a potentially safer alternative.
methods:  A systematic review of the literature was conducted to identify studies comparing the use of ibuprofen or indomethacin for 
closure of patent arterial duct in preterm infants. Baseline characteristics of these studies was compared and a meta-analysis conducted. 
The primary was point was ductal closure with secondary end points examining potential adverse effects. Analysis was conducted 
separately for different routes of ibuprofen and indomethacin administration: oral versus oral, oral versus intravenous, and intravenous 
versus intravenous.
results:  A total of 22 studies with 1,583 patients were included in the analysis. There was no difference noted in ductal closure rates 
between ibuprofen and indomethacin for comparable routes of administration as well as when oral ibuprofen was compared to intravenous 
indomethacin. When comparing oral ibuprofen versus oral indomethacin and intravenous ibuprofen versus intravenous indomethacin there 
was an association with less increase in creatinine with ibuprofen. No other significant differences iin adverse effects were noted.
Conclusion:  Oral or intravenous ibuprofen is equally effective in closing the preterm arterial duct as either oral or intravenous 
indomethacin. Indomethacin is associated with less increase in creatinine, thus making it a safe and effective alternative.
